From AVT Pilot to Enterprise Deployment: Why Most Trusts Get Stuck at Stage Two

Ambient voice technology has moved quickly. In many ways, it has moved faster than the frameworks being used to evaluate it.

A lot of healthcare organisations are now making, or preparing to make, significant procurement decisions about clinical AI documentation platforms. The problem is that many of the criteria being used to assess those platforms were designed for a different type of technology problem.

That is why the same pattern keeps appearing across health systems: a product performs well in a pilot, clinicians like the output, the evaluation looks positive, but the organisation then struggles to turn that early promise into enterprise-wide benefit.

The technology is not always the issue. Sometimes, the evaluation process is.

Feature evaluation versus workflow evaluation

Most AVT procurements still start with a feature comparison.

- Transcription accuracy
- Note quality
- EHR integration
- Supported specialties
- Price per user

All of these things are important and  they should absolutely be assessed. But on their own, they do not tell you whether a deployment will or wont work at scale. 

The questions that really predict enterprise success are different. 

• Does the platform support the full documentation workflow, or only the consultation note? 

• What happens after the note is created? How are letters, referrals, correspondence, approvals, distribution and audit handled? 

• What happens when a clinician does not want to use ambient AI? Is there an alternative route within the same governed environment, or does that clinician sit outside the deployment model entirely? 

• What governance infrastructure does the vendor provide? Is it genuinely built into the platform and deployment approach, or is it something the organisation has to work out after procurement? 

• Can the vendor demonstrate deployment across complex, multi-site healthcare environments? 
  

These are not just feature questions. They are workflow, governance and operational questions. And they are often the difference between a tool that works for individual clinicians and a platform that works for an enterprise healthcare organisation. 

The multi-modal adoption problem 

One of the biggest assumptions in AVT deployment is that ambient AI will suit the whole clinical workforce. 

It will not. 

In any large organisation, some clinicians will adopt ambient AI quickly. Others will prefer established speech recognition workflows. Others may have legitimate concerns about consent, data handling, clinical safety, or simply the disruption of changing how they document care. 

That variation is normal. It should be planned for. 

If a platform only offers ambient AI, it has no real answer for those second and third groups. Those clinicians either do not adopt, or they sit outside the benefits of the programme. The result is a deployment that reaches part of the organisation, rather than the organisation as a whole. 

That matters, because projected benefits rarely come from partial adoption.

T-Pro has been built around this reality. Ambient AI, speech recognition and structured documentation workflows sit within one centrally managed platform. That is not a secondary feature. It is what allows organisations to support different clinical preferences while maintaining a single governance, safety and operational model.

In practice, that can be the difference between reaching a small group of early adopters and creating a documentation environment that works across the full clinical population.

Governance should be a procurement criterion, not an afterthought 

Healthcare AI governance has moved from a background concern to a core procurement issue. 

Regulatory expectations are evolving across the UK, Ireland, Australia and other markets. Clinical safety expectations are increasing. Data protection requirements are being applied with greater scrutiny. Boards and executive teams are rightly asking harder questions about accountability, assurance and ongoing oversight. 

The organisations that struggle most are often those that separate governance from vendor selection. 

They choose a platform based on clinical usability and technical features, then discover later that the governance, compliance and assurance infrastructure they need is either incomplete, unclear, or left largely for their own teams to build. 

T-Pro takes a different approach. 

The AVT Governance Compliance Packs, created by T-Pro’s CCIO and Clinical Safety Officer Ben Jeeves, are designed to help healthcare organisations assess ambient voice technology before procurement decisions are made. They provide structured guidance across clinical safety and risk management, data protection and confidentiality, medical device and AI regulatory considerations, cybersecurity and resilience, and supplier assurance. 

As Ben Jeeves puts it:  “Healthcare organisations need more than a successful AVT pilot. They need a structured way to assess safety, accountability, regulatory readiness and enterprise scalability."

That is the point. Governance should not be retrofitted after a vendor has been selected. It should shape the procurement decision from the start.

What confident AVT procurement looks like 

The organisations that get AVT procurement right tend to have a few things in common. 

They evaluate the full workflow, not just the consultation note. Their tender specification looks beyond transcription and summary quality. It considers correspondence generation, routing, approval, distribution, audit and the wider documentation lifecycle. If a vendor cannot walk through that end-to-end process clearly, they are probably not ready for enterprise deployment. 

They plan for the full clinical population, not just early adopters. They ask how the platform supports different clinician preferences, different specialties, different documentation styles and different levels of confidence with ambient AI. They know that adoption is not uniform, and their deployment model reflects that from day one. 

They put governance in place before go-live. They understand the clinical safety case. They complete the right data protection assessment. They know how the vendor’s regulatory position aligns with their market. They have a model for ongoing monitoring, assurance and improvement as the technology and regulatory landscape continue to evolve. 

Procurement done this way leads to deployments that scale. 

And only deployments that scale can deliver the operational return that organisations are looking for. 

To download the T-Pro AVT Governance Compliance Pack for your region here.

To discuss enterprise deployment for your organisation, speak to the T-Pro team.: https://info.tpro.io/talk-to-sales